Vitamin D Supplementation in Vitamin D Deficient Obese Children During Weight-loss Program

• Status: Unknown status
• Trial end date: 2019-02-01
• Target enrollment: 0
• Participant gender: All

Summary

1. Analyze the influence of vitamin D supplementation in obese children during weight-loss program on BMI, body composition and bone mineral density.

2. Analyze the influence of vitamin D supplementation on the risk profile of obesity-related complications, namely impaired tolerance of glucose, insulin resistance, dyslipidemia and arterial hypertension, in obese children participating in weight-loss program.

3. Analyze the prevalence of vitamin D deficiency among obese children.

4. Analyze the risk factors of vitamin D deficiency in obese children (age, gender, pubertal status).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Clinical Centre, Gdansk
• Collaborator: Nutricia Foundation
• Treatments: Cholecalciferol; Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• overweight (BMI between the 85th and 95th percentile) or obesity (BMI > 95th percentile), identified on the basis of anthropometric parameters

• blood concentration of 25(OH)D3 < 30 ng/ml

• written consent of legal guardians

Exclusion Criteria:

• Chronic conditions (asthma or allergies, inflammatory diseases of connective tissue, gastrointestinal disorders, diseases of kidneys and liver, disorders of bone metabolism)

• Contraindications to administration of vitamin D

• Administration of any preparation containing vitamin D, calcium, or steroid hormones during 3 months preceding the study